Chinese Journal of Tissue Engineering Research ›› 2020, Vol. 24 ›› Issue (11): 1777-1782.doi: 10.3969/j.issn.2095-4344.2432

Previous Articles     Next Articles

Osteosarcopenic obesity syndrome: diagnosis, treatment and related influencing factors 

Chen Xingcai1, Kong Cunqing1, Xu Lin1, 2, Deng Qiongying1, 2   

  1. 1Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China; 2Key Laboratory of Human Development and Disease Research in Guangxi Universities, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • Received:2019-07-13 Revised:2019-07-18 Accepted:2019-08-23 Online:2020-04-18 Published:2020-02-29
  • Contact: Deng Qiongying, MD, Professor, Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China; Key Laboratory of Human Development and Disease Research in Guangxi Universities, Nanning 530021, Guangxi Zhuang Autonomous Region, China
  • About author:Chen Xingcai, Master, Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China Kong Cunqing, MD candidate, Department of Human Anatomy, School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China Chen Xingcai and Kong Cunqing contributed equally to this work.
  • Supported by:
     the National Natural Science Foundation of China, No. 31160222  and 31360259

Abstract:

BACKGROUND: Studies have shown that osteoporosis, sarcopenia and obesity are important factors affecting metabolic diseases such as fracture, hypertension and dyslipidemia.

OBJECTIVE: To describe the prevalence and influencing factors of osteosarcopenic obesity and its effects on racture and dyslipidemia, and to explore the role of diet and exercise in preventing osteosarcopenic obesity, so as to provide theoretical basis for the prevention and treatment of osteosarcopenic obesity.

METHODS: The related articles included in PubMed and WANFANG database published from 1990 to 2018 were searched using the following keywords: osteosarcopenic obesity, sarcopenic obesity, osteoporosis, sarcopenia, obesity, fracture, dyslipidemia, osteosarcopenic obesity syndrome. The language was limited to “English” or “Chinese.” A total of 71 articles were included for analysis and discussion.

RESULTS AND CONCLUSION: (1) The age, sex, nationality or race differences in prevalence of osteosarcopenic obesity have been found. (2) The diagnostic criteria of osteosarcopenic obesity, not international standard, have been established in the United States, Europe, Asia and others continents or countries; (3) Osteosarcopenic obesity is affected not only by living and eating habits, but also by genes, cytokines and metabolic hormones. (4) Osteosarcopenic obesity exerts greater impact on fracture and dyslipidemia compared with osteoporosis, sarcopenia and obesity alone. 

Key words: osteosarcopenic obesity, osteoporosis, sarcopenia, obesity, fracture, dyslipidemia

CLC Number: